Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001144204-17-059970
Filing Date
2017-11-17
Accepted
2017-11-17 16:43:47
Documents
6
Period of Report
2017-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q/A tv479682_10qa.htm 10-Q/A 42537
2 EXHIBIT 10.7 tv479682_ex10-7.htm EX-10.7 522722
3 EXHIBIT 31.1 tv479682_ex31-1.htm EX-31.1 8283
4 EXHIBIT 31.2 tv479682_ex31-2.htm EX-31.2 8004
5 EXHIBIT 32.1 tv479682_ex32-1.htm EX-32.1 4422
6 EXHIBIT 32.2 tv479682_ex32-2.htm EX-32.2 4326
  Complete submission text file 0001144204-17-059970.txt   591420
Mailing Address 16640 CHESTERFIELD GROVE ROAD SUITE 200 CHESTERFIELD MO 63005
Business Address BLOCK 10-1 BLANCHARDSTOWN CORPORATE PARK BALLYCOOLIN DUBLIN L2 15 636-449-1830
AVADEL PHARMACEUTICALS PLC (Filer) CIK: 0001012477 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 001-37977 | Film No.: 171211572
SIC: 2834 Pharmaceutical Preparations